Moreover, elevated levels of CCNB1 and PLK-1 are known to be strongly associated with low overall survival in other solid tumors like breast cancer, demonstrating their potentiality as prognostic markers and as combinatorial drug targets [53]. The gene discussed is PLK1; the disease is breast cancer.